Cargando…

Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma

Detalles Bibliográficos
Autores principales:	Xing, Fan, Xiao, Jingshu, Wu, Junyu, Liang, Jiaming, Lu, Xiaoyu, Guo, Liping, Li, Ping, Hou, Panpan, Li, Chunmei, Guo, Deyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316409/ https://www.ncbi.nlm.nih.gov/pubmed/34315854 http://dx.doi.org/10.1038/s41392-021-00609-0

Ejemplares similares

PTEN potentiation of oncolytic HSV therapy for glioblastoma
por: Migliarese, Christian, et al.
Publicado: (2023)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
por: Qi, Zhongbing, et al.
Publicado: (2022)

PTEN suppresses tumorigenesis by directly dephosphorylating Akt
por: Bu, Lang, et al.
Publicado: (2021)

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
por: Saha, Dipongkor, et al.
Publicado: (2017)

Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2018)

Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy
por: Marek, Janina, et al.
Publicado: (2023)

Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas
por: Petterson, Stine Asferg, et al.
Publicado: (2022)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
por: Angelova, Assia L., et al.
Publicado: (2017)

A novel phosphorylation site in SARS-CoV-2 nucleocapsid regulates its RNA-binding capacity and phase separation in host cells
por: Wu, Junyu, et al.
Publicado: (2022)

Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy
por: Li, Shuwen, et al.
Publicado: (2017)

Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
por: Tang, Xiangjun, et al.
Publicado: (2022)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Oncolytic Virus-Induced Autophagy in Glioblastoma
por: Kamynina, Margarita, et al.
Publicado: (2021)

Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment
por: Wang, Xiaoxi, et al.
Publicado: (2021)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

Modeling Oncolytic Viral Therapy, Immune Checkpoint Inhibition, and the Complex Dynamics of Innate and Adaptive Immunity in Glioblastoma Treatment
por: Storey, Kathleen M., et al.
Publicado: (2020)

The RNA polymerase of cytoplasmically replicating Zika virus binds with chromatin DNA in nuclei and regulates host gene transcription
por: Li, Ping, et al.
Publicado: (2022)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
por: Russell, Luke, et al.
Publicado: (2018)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
por: Xie, Daoyuan, et al.
Publicado: (2023)

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
por: Zhao, Rongrong, et al.
Publicado: (2021)

Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
por: Montemurro, Nicola, et al.
Publicado: (2023)

Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas
por: Xie, Shaozhen, et al.
Publicado: (2020)

The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review
por: Swildens, Kyra X, et al.
Publicado: (2022)

Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII(+)PTEN(−) glioblastoma in vivo
por: Xu, Wen, et al.
Publicado: (2016)

Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
por: Zhang, Bin, et al.
Publicado: (2021)

Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma
por: Wang, Shiqun, et al.
Publicado: (2023)

Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
por: Francis, Lily, et al.
Publicado: (2016)

Endogenous reverse transcriptase and RNase H-mediated antiviral mechanism in embryonic stem cells
por: Wu, Junyu, et al.
Publicado: (2021)

Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
por: Chen, Lishu, et al.
Publicado: (2022)

Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
por: Stavrakaki, Eftychia, et al.
Publicado: (2021)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
por: Webb, Mason J., et al.
Publicado: (2023)

Clinical trial links oncolytic immunoactivation to survival in glioblastoma
por: Ling, Alexander L., et al.
Publicado: (2023)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

PTEN action in leukemia dictated by the tissue microenvironment
por: Miething, Cornelius, et al.
Publicado: (2014)

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
por: Oseledchyk, Anton, et al.
Publicado: (2018)

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
por: Sivanandam, Venkatesh, et al.
Publicado: (2019)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
por: Xue, Liting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74njvelmlsqet7h9sss1rjqfb1